122 related articles for article (PubMed ID: 16730717)
1. Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer.
Pathirage N; Di Nezza LA; Salmonsen LA; Jobling T; Simpson ER; Clyne CD
Fertil Steril; 2006 Aug; 86(2):469-72. PubMed ID: 16730717
[TBL] [Abstract][Full Text] [Related]
2. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
Hussein-Fikret S; Fuller PJ
Mol Cell Endocrinol; 2005 Jan; 229(1-2):149-60. PubMed ID: 15607539
[TBL] [Abstract][Full Text] [Related]
3. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
[TBL] [Abstract][Full Text] [Related]
4. Expression of steroid receptor coactivators in cultured cells from paired myometrial and fibroid tissues.
Hussein-Fikret S; Fuller PJ; Gargett CE
J Soc Gynecol Investig; 2005 Sep; 12(6):445-51. PubMed ID: 15979354
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D analogs and coactivators.
Eelen G; Verlinden L; De Clercq P; Vandewalle M; Bouillon R; Verstuyf A
Anticancer Res; 2006; 26(4A):2717-21. PubMed ID: 16886682
[TBL] [Abstract][Full Text] [Related]
7. Connections and regulation of the human estrogen receptor.
McDonnell DP; Norris JD
Science; 2002 May; 296(5573):1642-4. PubMed ID: 12040178
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
[TBL] [Abstract][Full Text] [Related]
9. [Estrogen receptor beta--structure, regulation and function].
Tkaczyk M; Kalita K
Postepy Biochem; 2001; 47(1):72-9. PubMed ID: 11503442
[No Abstract] [Full Text] [Related]
10. Targeting steroid receptor coactivator-1 expression with locked nucleic acids antisense reveals different thresholds for the hormonal regulation of male sexual behavior in relation to aromatase activity and protein expression.
Charlier TD; Harada N; Ball GF; Balthazart J
Behav Brain Res; 2006 Sep; 172(2):333-43. PubMed ID: 16797739
[TBL] [Abstract][Full Text] [Related]
11. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.
Bramlett KS; Wu Y; Burris TP
Mol Endocrinol; 2001 Jun; 15(6):909-22. PubMed ID: 11376110
[TBL] [Abstract][Full Text] [Related]
12. Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines.
Monroe DG; Johnsen SA; Subramaniam M; Getz BJ; Khosla S; Riggs BL; Spelsberg TC
J Endocrinol; 2003 Mar; 176(3):349-57. PubMed ID: 12630920
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY
Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P
Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
16. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
[TBL] [Abstract][Full Text] [Related]
17. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease.
Ishunina TA; van Beurden D; van der Meulen G; Unmehopa UA; Hol EM; Huitinga I; Swaab DF
Neurobiol Aging; 2005 Feb; 26(2):173-94. PubMed ID: 15582747
[TBL] [Abstract][Full Text] [Related]
18. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptor coregulators in normal and malignant human endometrium.
Kershah SM; Desouki MM; Koterba KL; Rowan BG
Gynecol Oncol; 2004 Jan; 92(1):304-13. PubMed ID: 14751175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
